Published in Arzneimittelforschung on January 01, 1978
The digoxin-quinidine interaction: serum protein binding unlikely to be involved. Br J Clin Pharmacol (1981) 0.75
Serum amino acid concentrations in nine athletes before and after the 1993 Colmar ultra triathlon. Int J Sports Med (1995) 1.09
Tenascin and aggrecan expression by articular chondrocytes is influenced by interleukin 1beta: a possible explanation for the changes in matrix synthesis during osteoarthritis. Ann Rheum Dis (2004) 0.91
Activation of Evi1 inhibits cell cycle progression and differentiation of hematopoietic progenitor cells. Leukemia (2012) 0.87
[Pancreatitis associated with visceral lupus erythematosus]. Gastroenterologia (1967) 0.83
Relationship between postprandial metabolomics and colon motility in children with constipation. Neurogastroenterol Motil (2013) 0.82
The sensitivity of acoustic cough recording relative to intraesophageal pressure recording and patient report during reflux testing. Neurogastroenterol Motil (2014) 0.82
Generation of iPSCs from genetically corrected Brca2 hypomorphic cells: implications in cell reprogramming and stem cell therapy. Stem Cells (2014) 0.80
[Partition coefficients and Rm-values of cardenolides (author's transl)]. Arzneimittelforschung (1978) 0.79
[Lipophilicity and enteral absorption of cardenolides (author's transl)]. Arzneimittelforschung (1978) 0.78
[Morbidity after mitral valve replacement]. Thoraxchir Vask Chir (1972) 0.78
[Concentration of cardiac glycosides in the heart and brain (author's transl)]. Arzneimittelforschung (1976) 0.78
Comparison of the pharmacokinetics of digoxin and dihydrodigoxin in cats in single-dose studies. Naunyn Schmiedebergs Arch Pharmacol (1978) 0.78
[On the pharmacology of the alpha-receptor blocker BE 2254 (HEAT) (author's transl)]. Arzneimittelforschung (1980) 0.78
[Studies on Xipamide (4-chloro-5-sulfamoyl-2',6'-salicyloxylidide). Part 1: Physico-chemical and chemical properties (author's transl)]. Arzneimittelforschung (1977) 0.77
[Synthesis and characterization of some cardenolide glucuronides and sulphates (author's transl)]. Arzneimittelforschung (1977) 0.77
[Studies on the refractory, supernormal, and vulnerable phases of the heart in patients with bradycardias]. Arch Kreislaufforsch (1972) 0.75
[Effect of antiarrhythmic agents on diastolic stimulation threshold in human heart]. Arzneimittelforschung (1971) 0.75
[Patients with a pacemaker in street traffic]. Hefte Unfallheilkd (1970) 0.75
[Form analysis of central venous pressure curves. I. Normal curves]. Z Kreislaufforsch (1971) 0.75
[Proceedings: Early and late results after mitral-valve replacement (author's transl)]. Langenbecks Arch Chir (1973) 0.75
[Urinary copper excretion from rats following administration of aliphatic and alicyclic polyamines (author's transl)]. Arzneimittelforschung (1980) 0.75
[Syncope in the carotid sinus syndrome and its treatment]. Internist (Berl) (1973) 0.75
The importance of intensive monitoring and electro-therapy of coronary heart diseases. Angiology (1967) 0.75
[Clinical study on digoxin tablets with high bioavailability (author's transl)]. Arzneimittelforschung (1979) 0.75
[Form analysis of central venous pressure curves. 3. Changes in ventricular compliance]. Z Kreislaufforsch (1972) 0.75
[Digitoxin plasma concentrations during oral treatment (author's transl)]. Arzneimittelforschung (1981) 0.75
[Figural analysis of central venous pressure curves. II. Tricuspid valve insufficiency]. Z Kreislaufforsch (1971) 0.75
[Studies on determining the mutagenicity risk of triethylenetetramine (author's transl)]. Arzneimittelforschung (1981) 0.75
Relationship between dose and plasma level of digoxin and patient characteristics. Eur J Clin Pharmacol (1979) 0.75
[The saluretic effect of xipamide (4-chloro-5-sulfamoyl-2',6'-salicyloxylilide) in normal subjects]. Arzneimittelforschung (1975) 0.75
[Multicenter clinical study on therapy with digoxin tablets with high bioavailability (author's transl)]. Arzneimittelforschung (1979) 0.75
[Relationship between digoxin plasma concentrations and frequency of digoxin intoxication (author's transl)]. Arzneimittelforschung (1981) 0.75
[Artificial respiration in acute severe left heart failure (pulmonary edema)]. Z Kardiol (1973) 0.75
[Course of diuresis in heart failure during ethacrynic acid and amiloride therapy]. Munch Med Wochenschr (1971) 0.75
The influence of polar and non-polar digoxin and digitoxin metabolites on the 86Rb-uptake of human erythrocytes and the contractility of guinea pig papillary muscles. Arzneimittelforschung (1977) 0.75
[Enhanced bioavailability of digoxin from silica matrix formulations (author's transl)]. Arzneimittelforschung (1978) 0.75
Correlation between inhibition of (Na+, K+)-membrane-ATPase and positive inotropic activity of cardenolides in isolated papillary muscles of guinea pig. Naunyn Schmiedebergs Arch Pharmacol (1978) 0.75
[Saluretic and diuretic effects of xipamide-triamterene combinations in varying dose ratios in rats]. Arzneimittelforschung (1983) 0.75
[Inhibition of carbonic anhydrase by xipamide (4-chloro-sulfamoyl-2',6'-salicyloxylidide) in the modified Philpot test]. Arzneimittelforschung (1975) 0.75
[Pharmacokinetics of xipamide and triamterene in healthy probands]. Arzneimittelforschung (1982) 0.75
[Studies on xipamide (4-chlor-5-sulfamoyl-2',6'-salicyloxylidide). Part II. Pharmacokinetics in man]. Arzneimittelforschung (1977) 0.75
[Drug release in vitro from digoxin formulations with high bioavailability (author's transl)]. Arzneimittelforschung (1980) 0.75
[Influencing of the experimental hypoxia-induced cardiac hypertrophy in the mouse using digitoxin]. Z Kreislaufforsch (1968) 0.75
[Pulmonary hypertension after the installation of mitral valve prosthesis]. Verh Dtsch Ges Kreislaufforsch (1970) 0.75
[Mitral valve insufficiency following valve prosthesis using an autologous fascia lata valve]. Z Kardiol (1973) 0.75
[Protein binding of xipamide (4-chloro-5-sulfamoyl-2',6'-salicyloxylidide]. Arzneimittelforschung (1975) 0.75
[Electrocardiographic observations in retrograde ventriculoatrial conduction]. Z Kreislaufforsch (1971) 0.75
[Affinity of polar digoxin and digitoxin metabolites for digoxin and digitoxin antibodies]. Arzneimittelforschung (1977) 0.75